Shares of HIMS experienced a dramatic drop today following the unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending its stock price plummeting by more than fifteen percent. The reason for the collapse of the partnership remains u